SugarLand Announces Project Launch
New York, NY, Apr 27, 2022 – (ACN Newswire) – SugarLand, a Binance Smart Chain…
News
Trellix Finds Escalation of Cyberattacks Targeting Critical Infrastructure as Geopolitical Tensions Rise
New Report Details Wiper Malware Aimed at Ukraine and Upsurge in Cyber Threats from Likely…
Cloud DX Announces Closing of Private Placement
Waterloo, Ontario–(Newsfile Corp. – April 26, 2022) – Cloud DX Inc. (TSXV: CDX) (OTCQB: CDXFF) (“Cloud”…
OneStream and Data Hive Announce Strategic Partnership to Help Organizations Drive Digital Transformation Across Finance Functions
Industry leader and OneStream partner brings deep domain expertise and extensive implementation experience to the…
CORRECTING and REPLACING Emergent Cold Latin America Acquires Frigometro
Addition of Colombia’s market leader and entry into the fourth-largest economy in Latin America. SÃO…
Acerus Announces Completion of Share Consolidation
TORONTO, April 26, 2022 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP;…
SCYNEXIS Announces Closing of $45 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants
JERSEY CITY, N.J., April 26, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (Nasdaq: SCYX) today announced…
BioSyent to Present at 2022 Bloom Burton & Co. Healthcare Investor Conference
MISSISSAUGA, Ontario, April 26, 2022 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) is…
Berkeley Lights to Report First Quarter 2022 Financial Results on May 9, 2022
EMERYVILLE, Calif., April 26, 2022 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader…
ProQR to Present at the Retinal Cell and Gene Therapy Innovation Summit and the Association for Research in Vision and Ophthalmology (ARVO) 2022
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 26, 2022 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:…
Paratek Pharmaceuticals to Report First Quarter 2022 Financial Results on May 4, 2022
BOSTON, April 26, 2022 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that…
Jasper Therapeutics Announces Updated Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Older Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Undergoing Hematopoietic Cell Transplantation
JSP191 is well tolerated with no treatment-related severe adverse events in 24 patients with myelodysplastic…
RZ358 Phase 2b (RIZE Study) Topline Data to be Unveiled at Pediatric Endocrine Society Annual Meeting on May 1, 2022
Rezolute to host conference call presentation and discussion of the data on Sunday, May 1…
Galapagos announces appointment of Dr. Paul Stoffels as Chairman of the board
Mechelen, Belgium; 26 April 2022, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announces…
Collegium to Host Conference Call to Discuss First Quarter 2022 Financial Results
STOUGHTON, Mass., April 26, 2022 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading,…
Avid Introduces New Pro Tools Subscription Offerings that Empower Music Creators at Every Level of Experience
New Pro Tools subscription offering for entry-level musicians, plus enhanced functionality and new virtual instruments,…
Sanofi: Information concerning the total number of voting rights and shares – March 2022
Information concerning the total number of voting rights and shares, provided pursuant to article L….
Smart City Services International Announces the Addition of iSIGN Media’s HALOfx Tracing and Messaging Technology to its Private and Public Transit Partners
IRVINE, Calif., April 26, 2022 (GLOBE NEWSWIRE) — Smart City Services International (SCSI) is pleased…
World’s Largest Green Hydrogen Hub Selects Black & Veatch as EPC Provider
Global decarbonization solutions leader to play key role in first-of-its kind, utility-scale Advanced Clean Energy…
Fidelis Cybersecurity Active XDR Platform Expands to Open XDR
Faster, Stronger Detection, Deception and Response Quickly Neutralizes Advanced Threats BETHESDA, Md.–(BUSINESS WIRE)–#Cybersecurity–Fidelis Cybersecurity, the…